Skip to main content
Caplight Logo









MeOmics

MeOmics

Private
CardiffHealthcare & Life Scienceshttps://meomics.tech/

Last Round

Angel

Feb 9, 2026

Total Funding Raised

$627,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

MeOmics is a biotechnology company that provides a precision psychiatry platform using patient-derived neurons and AI to improve psychiatric drug development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Mental Health, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Usage-Based SaaS

AI Layer

Application

Keywords

precision psychiatrydrug screening platformAI drug discoverypatient-derived stem cellsiPSChuman neuron modelsbrain organoidspsychiatric drug developmentdisease-in-a-dishpatient stratificationdrug response predictionclinical trial optimizationschizophreniaelectrophysiologyhigh-throughput screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MeOmics Comparables

Compare MeOmics with similar companies based on industry and business-model similarity.

MeOmics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Organotics
83%
NeuroKaire
79%
Herophilus
78%

MeOmics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelFeb 9, 2026
Pre SeedMay 9, 2022

Key People

Founding team and executive leadership

Lucy Sykes

Chief Executive Officer

Executive Team

Alasdair Pettigrew

COO CCO & Board Chair

Executive Team

MeOmics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 25, 2026

    Grew 43% QoQ from 7 to 10 employees.

  • Feb 9, 2026

    $408K round led by Women Angels of Wales.

MeOmics Filings

Explore SEC and related filing metadata, where available.

MeOmics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MeOmics's valuation, stock price, and market status.

Is MeOmics a public or private company?

MeOmics is a private company.

What is the current stock price of MeOmics?

MeOmics is a private company with no public stock price. No recent secondary market data is available.

How much is MeOmics worth (valuation)?

Valuation information for MeOmics is not publicly available.

Can I buy MeOmics stock?

MeOmics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MeOmics's last funding round?

MeOmics's most recent funding round was Angel on February 9, 2026.

Who are the main investors in MeOmics?

Key investors in MeOmics include Women Angels of Wales.

Will MeOmics IPO soon?

No public IPO plans have been announced for MeOmics.

How can I track MeOmics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MeOmics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCardiff
Employee Range8
Year Founded2020
Last FundingFeb 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?